Conversion to sirolimus in African American renal allograft recipients undergoing early steroid withdrawal: intermediate-term risks and benefits. [electronic resource]
Producer: 20100528Description: 1161-2 p. digitalISSN:- 1534-6080
- Adrenal Cortex Hormones -- therapeutic use
- Adult
- Antibodies, Monoclonal -- therapeutic use
- Antilymphocyte Serum
- Black People
- Drug Administration Schedule
- Female
- Follow-Up Studies
- Hepatitis C -- epidemiology
- Humans
- Immunosuppressive Agents -- therapeutic use
- Kidney Transplantation -- immunology
- Male
- Methylprednisolone -- therapeutic use
- Middle Aged
- Mycophenolic Acid -- analogs & derivatives
- Renal Dialysis
- Reoperation -- statistics & numerical data
- Risk Assessment
- Sirolimus -- therapeutic use
- Tacrolimus -- therapeutic use
- Transplantation, Homologous
- Black or African American
No physical items for this record
Publication Type: Letter; Comment
There are no comments on this title.
Log in to your account to post a comment.